Last €0.99 EUR
Change Today +0.02 / 2.07%
Volume 0.0
AQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 2:16 AM 09/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paolo Pucci

Chief Executive Officer and Director, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 40 board members in 3 different organizations across 5 different industries.

See Board Relationships
52$1,233,620
As of Fiscal Year 2013

Background*

Mr. Paolo Pucci has been Chief Executive Officer of ArQule Inc. since June 2008. Mr. Pucci served as the President of Global Specialty Business Unit and Senior Vice President of Bayer HealthCare LLC of Bayer Corporation where he served as President in charge of the Bayer-Schering Pharmaceuticals Global Oncology/Specialized Therapeutics Business Units. He served as Senior Vice President of Bayer Pharmaceuticals Global Specialty Business Unit, President of U.S. Pharmaceutical ...

Read Full Background

Corporate Headquarters*

19 Presidential Way
Woburn, Massachusetts 01801

United States

Phone: 781-994-0300
Fax: 781-376-6019

Board Members Memberships*

2008-Present
Chief Executive Officer and Director
2011-Present
Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
2013-Present
Director

Education*

MBA
The University of Chicago
Unknown/Other Education
Universita' degli Studi di Napoli Federico II

Other Affiliations*

Annual Compensation*

Salary$489,345
Total Annual Compensation$489,345

Stock Options*

All Other Compensation$8,100
Exercisable Options997,500
Unexercisable Options727,500
Total Number of Options1,725,000

Total Compensation*

Total Annual Cash Compensation$747,011
Total Short Term Compensation$489,345
Other Long Term Compensation$8,100
Total Calculated Compensation$1,233,620
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AQL:GR €0.99 EUR +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Tuan Ha-Ngoc Chief Executive Officer, President and Director
AVEO Pharmaceuticals, Inc.
$567.9K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.